Avid Bioservices Inc (CDMO)

[dia76ca]

MARY BOYD IS HEAD OF BUS.DEV.FOR ASIA AND EUROPE.

Maybe we should take this job description seriously! Maybe this gives us a clue that the company intends to partner first of all in Asia and then in Europe and then finally in the big North American market! Dr. Boyd has vital business connections in Japan. Japan is a very big market on its own but because of language and cultural factors it is very hard to penetrate. You must have personal connections. You must have personal trust and respect. Mary has been there and has these connections.

There are some very big, knowledgeable and progressive Japanese pharma. I know other biotechs who have signed their first partnership with Japanese pharma...then partnered up in Europe and then then finally in North America.

As far as Europe goes, she has Roche connections. Roche owns 55% of Genentech(Avastin) and is trying to buy up what it does not own. It has about $40 billion in reserves and just the other day floated another $18 billion in bonds. It has also told Genentech that Genentech is overvaluing future Avastin sales. Do you think Roche knows about Bavi? Do you think Roche might be interested in Bavi?

I bet Mary has been speaking to Japanese pharma as well as Genentech and Roche(Swiss) and other European big pharma. You know it just could be that the management of this company are doing a good job!